Organization Overview
Alternative names
asparaginase (elspar) (2 trials)
blinatumomab (blincyto) (2 trials)
bone marrow derived mononuclear cells (1 trial)
bortezomib (velcade) (2 trials)
carboplatin (paraplatin) (2 trials)
cytarabine (cytosar-u) (4 trials)
daunorubicin (cerubidine) (4 trials)
dimethyl fumarate (tecfidera) (1 trial)
doxorubicin (Doxil) (4 trials)
erwinia asparaginase (Erwinaze) (1 trial)
etoposide (vepesid) (4 trials)
fludarabine (fludara) (3 trials)
allogeneic hematopoietic stem cells (Hemacord) (1 trial)
alteplase (Activase) (1 trial)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (1 trial)
Back Pain (Phase 4)
Cadaver (Phase 1)
Carcinoma, Ovarian Epithelial (Phase 3)
Carcinoma, Transitional Cell (Phase 3)
Churg-Strauss Syndrome (Phase 2)
Colitis (Phase 2)
Colitis, Ulcerative (Phase 2)
Colorectal Neoplasms (Phase 3)
Dermatitis (Phase 2)
Dermatitis, Atopic (Phase 2)
Eczema (Phase 2)
Esophageal Neoplasms (Phase 2)
Fallopian Tube Neoplasms (Phase 3)
Genital Neoplasms, Female (Phase 3)
Hyperalgesia (Phase 1)
Kidney Neoplasms (Phase 3)
Leukemia (Phase 3)
Leukemia, Large Granular Lymphocytic (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 3)
Low Back Pain (Phase 4)
Melanoma (Phase 2)
Neuralgia (Phase 4)
Pancreatic Neoplasms (Phase 3)
Peripheral Nervous System Diseases (Phase 4)
Psoriasis (Phase 3)
Respiratory Aspiration (Phase 3)
Rosacea (Phase 2)
Sarcoma (Phase 2)
Syndrome (Phase 2)
Thyroid Diseases (Phase 2)
Thyroid Neoplasms (Phase 2)
Ulcer (Phase 2)
Ureteral Neoplasms (Phase 3)
Urethral Neoplasms (Phase 3)
Urinary Bladder Neoplasms (Phase 3)
Vomiting (Phase 3)